Novartis terminates phase III KontRASt-02 trial of JDQ443 in lung cancerNov 6Trial updateNovartisopnurasib
Novartis registers new Phase 2 NIO752 tauopathy trial; Egaten results, six studies updateOct 9Weekly roundup, 8 itemsinclisiraniptacopanUpdated
Sign inSign in